|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
PhytoHealth Corp. (怀特生技新药)
Main Activities: Professional, Scientific, and Technical Services
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name PhytoHealth Corp. (怀特生技新药) Headquarters 5-1/F, 167, Fu Hsin N. Rd., Taipei, Taiwan; New Taipei City; New Taipei City |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational ISIN CODE : TW0004108006 Financial Auditors: Kwang-I & Co., CPAs (2013) Incorporation Date: November 24, 1998 Total Employees: 57 Tel: 886-2-25453697 |
|
Company Description |
| PhytoHealth Corp. was founded in November 1998 and was listed in OTC as emerging stocks. PhytoHealth is principally engaged in the research, development and licensing of western drugs, cosmetics and healthcare products. The company operates its businesses through the development of new drugs, which provides PHN011, PHN012, PHN013, PHN031, PHN081, PHN121 and PHN131 for the treatment of car sick, sea sick, air sick, marrow depression, osteoporosis and cough, as well as healthcare food business, drug | ||
|
||
Key Executives |
|
|||||
|
|||||
|
|||||
|
FULL COMPANY PROFILE
|
|
2012 Y (non-cons) |
2012 Q3C (non-cons) |
|
 | ||
| Audited | Audited | |
| ||
| Unit | Millions | Millions |
| ||
Balance Sheet
| ||
Total Assets |
XXX |
XXX |
| ||
Current Assets |
XXX |
XXX |
| ||
Total Liabilities |
XXX |
XXX |
| ||
Shareholders Equity |
XXX |
XXX |
| ||
Current Liabilities |
XXX |
XXX |
| ||
| * All the accounts are in TWD. | ||
Income Statement
| ||
Total Operating Revenue |
XXX |
XXX |
| ||
Operational Profit (Loss) |
XXX |
XXX |
| ||
Net Profit (Loss) |
XXX |
XXX |
| ||
| * All the accounts are in TWD. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
XXX |
XXX |
| ||
Annualised Return on Assets (ROA) |
XXX |
XXX |
| ||
Return on Equity (ROE) |
XXX |
XXX |
| ||
Annualised Return on Equity (ROE) |
XXX |
XXX |
| ||
Return on Sales (ROS) |
XXX |
XXX |
| ||
Return on Capital |
XXX |
XXX |
| ||
Gross Profit Margin |
XXX |
XXX |
| ||
Operating Profit Margin |
XXX |
XXX |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
XXX |
XXX |
| ||
Inventory Turnover |
XXX |
XXX |
| ||
Current asset turnover |
XXX |
XXX |
| ||
Fixed-asset turnover |
XXX |
XXX |
| ||
Asset Turnover |
XXX |
XXX |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
XXX |
XXX |
| ||
EBITDA |
XXX |
XXX |
| ||
Enterprise value |
XXX |
XXX |
| ||
Enterprise Value / EBITDA |
XXX |
XXX |
| ||
Bookvalue (BV) |
XXX |
XXX |
| ||
Net Cash |
XXX |
XXX |
| Liquidity Ratios | ||
| ||
Current Ratio |
XXX |
XXX |
| ||
Quick ratio |
XXX |
XXX |
| ||
Doom's day ratio |
XXX |
XXX |
| ||
Cash Flow to Debt |
XXX |
XXX |
| Leverage Ratios | ||
| ||
Leverage ratio |
XXX |
XXX |
| ||
Interest Coverage Ratio |
XXX |
XXX |
| ||
Debt to equity |
XXX |
XXX |
| ||
Debt to total assets |
XXX |
XXX |
| ||
Debt / Enterprise Value |
XXX |
XXX |
| Market ratios | ||
| ||
Price/Book Ratio |
XXX |
XXX |
| ||
Market Cap / Net cash |
XXX |
XXX |
| Trend Ratios | ||
| ||
Revenue Trend |
XXX |
XXX |
| ||
Net Income Trend |
XXX |
XXX |
| ||
Operating Income Trend |
XXX |
XXX |
| ||
 |